Psilocybin for prolonged grief
Treatments studied
Part of Mental health clinical trials.
This trial tests if a single dose of psilocybin (a psychedelic drug) can help people with prolonged grief disorder. You'll receive counseling and be observed in a safe setting.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Age 18 to 65
- Diagnosed with prolonged grief disorder and a high grief score
- No recent use of certain illegal drugs or psychedelics
- Not pregnant or nursing, and must use effective birth control if sexually active
- Stable on current antidepressant medications (SSRI, SNRI, or bupropion) for at least 2 months
- Willing to stay at the study site for up to 10 hours and avoid certain medications and substances
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests whether a mindfulness program can help adults cope with intense grief after the loss of a loved one. If you have been diagnosed with Prolonged Grief Disorder and are not in other grief treatment, this may be an option for you.
This trial tests if psilocybin, a psychedelic drug, can help people with long-term low back pain who also have depression. If you qualify, you'll receive psilocybin in a controlled setting, and researchers will see how it affects your pain and mood.
This trial tests whether a psychedelic psilocybin session can help people who feel very lonely feel more connected to others. If you are medically healthy and often feel isolated, you may be able to join.
This study tests whether psilocybin, a naturally occurring psychedelic compound, can help people with depression who experience anhedonia—a loss of interest or pleasure in activities. Researchers will monitor your brain activity and mood changes over time to see if this treatment is safe and helpful.
This trial tests whether a single dose of psilocybin (a psychedelic medicine) can help reduce depression and distress in people with advanced lung disease, ALS, multiple sclerosis, or Parkinson's. You would receive preparation, the drug, and follow-up support in a safe, supervised setting.
This trial tests whether taking very small, repeated doses of psilocybin (a substance found in magic mushrooms) along with talk therapy can help people with depression that hasn't gotten better with other treatments. You'll need to stop your current depression medications and avoid drugs or alcohol for the study period.
Hear when a new Prolonged Grief Disorder trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.